Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Acceleron
Biotech
Merck posts fresh sotatercept data ahead of FDA approval ruling
Merck provided further safety and efficacy data ahead of a FDA ruling on whether to approve the jewel of its $11.5 billion Acceleron Pharma buyout.
Nick Paul Taylor
Sep 11, 2023 7:45am
Merck reveals HIV combo trial is back in the running
Apr 27, 2023 11:27am
Celgene, Acceleron alum Backstrom tapped to lead Scholar Rock
Sep 20, 2022 11:20am
Mystery suitor lines up $11B Acceleron acquisition: report
Sep 27, 2021 7:10am
In a first, FDA issues a serious rebuke for trial data delay
Apr 29, 2021 7:15am
Acceleron ditches midstage drug after flop
Mar 10, 2020 7:20am
